The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study

Journal:

The Lancet

Published:

2025-07-04

DOI:

10.1016/s0140-6736(25)00831-1

Affiliations:

7

Authors:

13

Go to article

Institutions	Authors	Share
Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland	5.500000	0.42
Harvard University, United States of America (USA)	3.000000	0.23
MRC Centre for Global Infectious Disease Analysis (MRC GIDA), United Kingdom (UK)	2.500000	0.19
Avenir Health, Inc., United States of America (USA)	2.000000	0.15

Interested in Applied Economics?